FDA/CDC
FDA/CDC
What to know about newly approved Alzheimer’s drug
The drug has shown moderate positive effects in clinical trials in slowing early...
FDA/CDC
FDA approves second antiamyloid for Alzheimer’s disease
Like its controversial cousin aducanumab, lecanemab was approved under the FDA’s accelerated approval pathway.
FDA/CDC
FDA considers regulating CBD products
The products can have drug-like effects on the body and contain CBD (cannabidiol) and THC (tetrahydrocannabinol).
News from the FDA/CDC
FDA puts REMS requirements on hold to ensure continuity of care
The FDA said it will temporarily not object if inpatient pharmacies dispense a days’ supply of clozapine that aligns with a patient’s monitoring...
Latest News
Eighty percent of U.S. maternal deaths are preventable: Study
“It’s significant. It’s staggering. It’s heartbreaking.”
FDA/CDC
FDA approves ‘rapid-acting’ oral drug for major depression
It is the "first and only rapid-acting oral medicine approved for the treatment of MDD.
FDA/CDC
FDA panel rejects pimavanserin for Alzheimer’s psychosis
The FDA will make its final decision by August 4.
FDA/CDC
FDA panel strongly backs protein-based Novavax COVID-19 vaccine
“Having a protein-based alternative may be more comfortable for some in terms of their acceptance of vaccines.”
FDA/CDC
FDA denies petition to disqualify researchers over controversial ketamine studies
“The FDA denied our petition, and we think that sends the wrong signal to the research community.”
FDA/CDC
Many Americans missing an opportunity to prevent dementia
“Health care professionals should also screen patients for modifiable risk factors, counsel patients with risk factors, and refer them to...
FDA/CDC
FDA clears diagnostic test for early Alzheimer’s
“There is a new option that can typically be completed the same day and can give doctors the same information regarding brain amyloid status,...